摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(-)-O-(N,N-dimethylaminoethyl)-cubebin

中文名称
——
中文别名
——
英文名称
(-)-O-(N,N-dimethylaminoethyl)-cubebin
英文别名
2-[(3S,4S)-3,4-bis(1,3-benzodioxol-5-ylmethyl)oxolan-2-yl]oxy-N,N-dimethylethanamine
(-)-O-(N,N-dimethylaminoethyl)-cubebin化学式
CAS
——
化学式
C24H29NO6
mdl
——
分子量
427.497
InChiKey
UBTZIBNJIZJWIK-WEAPTXNRSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    4
  • 重原子数:
    31
  • 可旋转键数:
    8
  • 环数:
    5.0
  • sp3杂化的碳原子比例:
    0.5
  • 拓扑面积:
    58.6
  • 氢给体数:
    0
  • 氢受体数:
    7

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为产物:
    描述:
    (-)-cubebin2-氯-N,N-二甲基乙胺sodium ethanolate 作用下, 以 乙醇 为溶剂, 反应 6.0h, 以71%的产率得到(-)-O-(N,N-dimethylaminoethyl)-cubebin
    参考文献:
    名称:
    Trypanocidal activity of (−)-cubebin derivatives against free amastigote forms of Trypanosoma cruzi
    摘要:
    Five (-)-cubebin derivative compounds, (-)-O-acetyl cubebin (3), (-)-O-benzyl cubebin (4), (-)-O-(N,N-dimethylaminoethyl)-cubebin (5), (-)-hinokinin (6) and (-)-6,6'-dinitrohinokinin (7), previously synthesised by our research group, were evaluated on in vitro assay against free amastigote forms of Trypanosoina cruzi, the asogic agent of Chagas' disease. It was observed that 6 was the most active compound (IC50 = 0.7 muM), and that 4 and 5 displayed moderate activity against the parasite, giving IC50 values of 5.7 and 4.7 muM, respectively. In contrast, it was observed that compound 3 was inactive and that 7 displayed low activity with IC50 values of congruent to1.5 x 10(4) and 95.3 muM, respectively. (C) 2004 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2004.10.079
点击查看最新优质反应信息

文献信息

  • Process To Obtain Dibenzylbutyrolactonic, Tetrahydrofuranic Lignans And Their Synthetic And Semi-Synthetic Derivatives, Their Analgesic And Anti-Inflammatory Activities, Topical And/Or Systemic Formulations Containing Said Lignans And Their Respective Therapeutic Method
    申请人:Silva Marcio Luis Andrade e
    公开号:US20080214661A1
    公开(公告)日:2008-09-04
    A process to obtain dibenzylbutyrolactonic lignans from (-)-cubebin, isolated from a Piperaceae, especially Piper cubeba, and from (-)-methylpluviatolide, isolated from a Rutacea, especially Zanthoxylum naranjillo; their synthetic and semi-synthetic derivatives and tetrahydrofuranic lignans, such as galgravin and veragensin, isolated from Nectandra megapotamica, as well as the analgesic and anti-inflammatory activities of said lignans, and the topical and/or systemic formulations. Also presented is a therapeutic method using topic and/or systemic formulations based on said lignans for the treatment of inflammation and/or pain. Further, a process to obtain synthetic and semi-synthetic derivatives of (-)-cubebin, such as: (-)—O-acetyl cubebin; (-)—O-methyl cubebin; (-)—O—(N,N-dimethylamino-ethyl)-cubebin; (-)-hinokinin; (-)- 6,6 ′-dinitroinokinin; (-)—O-benzyl cubebin; (-)- 6,6 ′-diaminohinokinin and other synthetic derivatives which may be obtained, and synthetic and semi-synthetic derivatives of (-)-methylpluviatolide, such as (-)- 6,6 ′-dinitromethylpluviatolide and (-)- 6,6 ′-diaminomethylpluviatolide, to be used in the manufacture of medicine that has analgesic and anti-inflammatory activity is presented.
  • Trypanocidal activity of (−)-cubebin derivatives against free amastigote forms of Trypanosoma cruzi
    作者:Vanessa A. de Souza、Rosangela da Silva、Ana C. Pereira、Vanessa de A. Royo、Juliana Saraiva、Marisa Montanheiro、Gustavo H.B. de Souza、Ademar A. da Silva Filho、Marcella D. Grando、Paulo M. Donate、Jairo K. Bastos、Sérgio Albuquerque、Márcio L.A. e Silva
    DOI:10.1016/j.bmcl.2004.10.079
    日期:2005.1
    Five (-)-cubebin derivative compounds, (-)-O-acetyl cubebin (3), (-)-O-benzyl cubebin (4), (-)-O-(N,N-dimethylaminoethyl)-cubebin (5), (-)-hinokinin (6) and (-)-6,6'-dinitrohinokinin (7), previously synthesised by our research group, were evaluated on in vitro assay against free amastigote forms of Trypanosoina cruzi, the asogic agent of Chagas' disease. It was observed that 6 was the most active compound (IC50 = 0.7 muM), and that 4 and 5 displayed moderate activity against the parasite, giving IC50 values of 5.7 and 4.7 muM, respectively. In contrast, it was observed that compound 3 was inactive and that 7 displayed low activity with IC50 values of congruent to1.5 x 10(4) and 95.3 muM, respectively. (C) 2004 Elsevier Ltd. All rights reserved.
查看更多